stockrowAMNEAL PHARMACEUTICALS, INC.
AMRX Healthcare Drug Manufacturers Specialty & Generic
AMNEAL PHARMACEUTICALS, INC.’s revenue for fiscal 2025 (year ended December 2025) was $3.0 billion, up 8.05% from fiscal 2024.
- Revenue
- +9.96%
- EPS
- +267.0%
- Free cash flow
- −50.9%
- Total debt
- +23.8%
Quarter to September 2026, against a year earlier
Follow AMRX
Alert me
AMNEAL PHARMACEUTICALS, INC. (AMRX) Gross margin
AMNEAL PHARMACEUTICALS, INC.'s gross margin over the twelve months to 30 September 2026 was 40.2%, up 3.4 percentage points from fiscal 2025 (36.9%). Over the past ten years it has ranged from 21.7% (fiscal 2019) to 58.7% (fiscal 2016); the current reading is higher than 64% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 53.5% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 36.9% | 0.36 |
| FY2024 | 36.5% | 2.24 |
| FY2023 | 34.3% | (1.19) |
| FY2022 | 35.5% | (1.26) |
| FY2021 | 36.7% | 5.19 |
| FY2020 | 31.5% | 9.84 |
| FY2019 | 21.7% | (21.38) |
| FY2018 | 43.1% | (7.82) |
| FY2017 | 50.9% | (7.78) |
| FY2016 | 58.7% | 17.73 |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 38.7% | (3.28) |
| Jun 2026 | 42.0% | (2.30) |
| Mar 2026 | 44.3% | 7.81 |
| Dec 2025 | 36.5% | 1.58 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| LQDA Liquidia Corporation compare | 92.5% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 90.2% |
| SUPN Indivior Pharmaceuticals Inc. compare | 84.9% |
| ALKS Alkermes plc compare | 82.9% |
| HIMS Hims & Hers Health, Inc. compare | 68.4% |
| LNTH Lantheus Holdings, Inc. compare | 61.3% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| AMRX AMNEAL PHARMACEUTICALS, INC. | 40.2% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on AMRX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement